Postprints from IHPS
Parent: Institute for Health Policy Studies
eScholarship stats: Breakdown by Item for December, 2024 through March, 2025
| Item | Title | Total requests | Download | View-only | %Dnld |
|---|---|---|---|---|---|
| 8g62x69s | Pharmaceutical Industry Sponsorship and Research Outcome and Quality: Systematic Review | 117 | 27 | 90 | 23.1% |
| 1p96m101 | How the tobacco industry responded to an influential study of the health effects of secondhand smoke | 101 | 5 | 96 | 5.0% |
| 9w2773tz | Science in Regulatory Policy Making: Case Studies in the Development of Workplace Smoking Restrictions | 90 | 5 | 85 | 5.6% |
| 458923p7 | Closing the Gap Between Research and Practice: An Overview of Systematic Reviews of Interventions to Promote Implementation of Research Findings by Health Care Professionals | 82 | 10 | 72 | 12.2% |
| 0qr8945r | Print Media Coverage of Research on Passive Smoking | 76 | 6 | 70 | 7.9% |
| 2mh5m74d | Evaluating Public Commentary and Scientific Evidence Submitted in the Development of A Risk Assessment | 43 | 13 | 30 | 30.2% |
| 4816j1zm | Evaluation of Probation Case Management (PCM) for Drug-Involved Women Offenders | 37 | 12 | 25 | 32.4% |
| 9b4848d9 | Tobacco Industry Response to a Risk Assessment of Environmental Tobacco Smoke | 37 | 4 | 33 | 10.8% |
| 5tk8j863 | Scientific Quality of Original Research Articles on Environmental Tobacco Smoke | 35 | 11 | 24 | 31.4% |
| 65k6g0xw | A Nicotine Delivery Device Without the Nicotine? Tobacco Industry Development of Low Nicotine Cigarettes | 33 | 4 | 29 | 12.1% |
| 05t2c9v4 | Does Centralized Intake Improve Drug Abuse Treatment Outcomes? | 30 | 10 | 20 | 33.3% |
| 3wx6m2hk | Making the Cigar News | 28 | 6 | 22 | 21.4% |
| 2mj527c4 | Cigar Magazines: Using Tobacco to Sell A Lifestyle | 25 | 6 | 19 | 24.0% |
| 9170d63n | The Limits of Competing Interest Disclosures | 23 | 5 | 18 | 21.7% |
| 2hp9d0q1 | Policy Makers’ Perspectives on Tobacco Control Advocates’ Roles in Regulation Development | 22 | 4 | 18 | 18.2% |
| 7v7675zg | Multi-Level Assessment Protocol (MAP) for Adoption in Multisite Clinical Trials | 21 | 8 | 13 | 38.1% |
| 6dp961gw | Perspectives on the Drug Court Model Across Systems: A Process Evaluation | 19 | 6 | 13 | 31.6% |
| 8kt152b8 | Accepting Commercial Sponsorship | 14 | 4 | 10 | 28.6% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.